Merck (MRK) earnings in Q4 2025

Merck on Tuesday reported fourth-quarter earnings and revenue that beat estimates due to strong demand for its Keytruda cancer immunotherapy…

Visa Drama: A Cautionary Story

Why it's always worth checking official sources to avoid the problems of misjudging visa restrictions, and what happens if you're…